Harrow to Present at Two Investor Conferences in May

NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following two investor conferences in May:

B. Riley Securities 25th Annual Investor Conference (The Ritz-Carlton, Marina del Rey, CA)
Format: Fireside Chat, followed by 1x1 Investor Meetings
Date/Time: Wednesday, May 21, 2025, through Thursday, May 22, 2025

Craig-Hallum 22nd Annual Institutional Investor Conference (Depot Renaissance Hotel, Minneapolis, MN)
Format: 1x1 and Small Group Investor Meetings
Date/Time: Wednesday, May 28, 2025

Investors interested in meeting with management during either conference should contact their B. Riley or Craig-Hallum representative to request a meeting. Neither event will be webcast.

About Harrow

Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250514227378/en/

Jamie Webb, Director of Communications and Investor Relations
[email protected]
615-733-4737

Source: Harrow, Inc.

You May Also Be Interested In

• INVIDI Technologies Collaborates with Google to Integrate Google Ad Manager for Unlocking Addressable Advertising for Tens of Millions of Unconnected Set-Top Boxes Globally
• SILITH and UMC Achieve Mass Production Milestone for Silicon Photonics
• Toshiba Expands Lineup of Quad-Channel Standard Digital Isolators, Will Contribute to Lower Power Consumption in Industrial Equipment